No Data
No Data
Earnings Preview: NeoGenomics to Report Financial Results Pre-market on April 29
$NeoGenomics(NEO.US)$ is scheduled to release its financial results pre-market on April 29 ET. Earnings PreviewAnalysts estimate $NeoGenomics(NEO.US)$ to post revenue of USD170.90M for 2025Q1, up 9.38
NeoGenomics Validates PanTracer LBx, A Blood Test for Comprehensive Tumor Profiling
NeoGenomics Analyst Ratings
Goldman Sachs Maintains NeoGenomics(NEO.US) With Buy Rating, Cuts Target Price to $15
TD Cowen Maintains NeoGenomics(NEO.US) With Buy Rating, Cuts Target Price to $17
Express News | Neogenomics Inc : TD Cowen Cuts Target Price to $17 From $19